🔎 Trials Near Me

Akèy › Obèsite › Florid › The Villages

Etid klinik pou Obèsite nan The Villages, FL

9 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote The Villages (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • Charter Research - The Villages /ID# 282376, The Villages
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Ap rekriteFaz 2
  • Charter Research LLC - The Villages, The Villages
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Charter Research - Lady Lake, The Villages
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, The Villages
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, The Villages
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Charter Research - Lady Lake, The Villages
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, The Villages
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3
  • Charter Research - The Villages, The Villages
Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Ap rekriteFaz 2
  • K2 Medical Research The Villages, The Villages
Laj 18 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT07477704

Etid Obèsite nan lòt vil

Lòt etid nan The Villages

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.